Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of N-acetylcysteine on Exacerbations of Bronchiectasis
NCT02088216Completed
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Apr 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of acetylcysteine in Non-cystic fibrosis bronchiectasis (NCFB) (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoint: Median Number of Exacerbations at 12 months. Started Apr 2014; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT02088216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02088216.